Oxygenta Pharmaceutical Ltd — Important, 20-02-2026: Company Update

Oxygenta Pharmaceutical has received a favorable order from the Appellate Joint Commissioner of State Tax, which has set aside a disputed demand of ₹0.41 Cr (Rupees Forty-One Lakhs Thirty-One Thousand Three Hundred and Fifty-One) against the company. This demand was related to Input Tax Credit for the 2017-18 tax period. The decision means the company is no longer liable for this amount, effectively removing a potential financial obligation and ensuring no adverse impact on its financial or operational position.